カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のレムデシビル（新型コロナウイルス感染症）市場2022年：5mg、10mg、50mg、100mg

◆英語タイトル：Global Remdesivir (COVID-19) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8953 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：92 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

レムデシビル（新型コロナウイルス感染症）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のレムデシビル（新型コロナウイルス感染症）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

レムデシビル（新型コロナウイルス感染症）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5mg、10mg、50mg、100mg

用途別セグメントは次のように区分されます。
・病院、クリニック、薬局、その他

世界のレムデシビル（新型コロナウイルス感染症）市場の主要な市場プレーヤーは以下のとおりです。
・Gilead Sciences、Bright Gene、Hainan Haiyao、Kelun Pharma、Hunan Warrant Pharmaceutical、Borui Bio-Pharmaceutical、Berry Global Group、Inovio Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、レムデシビル（新型コロナウイルス感染症）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なレムデシビル（新型コロナウイルス感染症）メーカーの企業概要、2019年～2022年までのレムデシビル（新型コロナウイルス感染症）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なレムデシビル（新型コロナウイルス感染症）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別レムデシビル（新型コロナウイルス感染症）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのレムデシビル（新型コロナウイルス感染症）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのレムデシビル（新型コロナウイルス感染症）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびレムデシビル（新型コロナウイルス感染症）の産業チェーンを掲載しています。
・第13、14、15章では、レムデシビル（新型コロナウイルス感染症）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences、Bright Gene、Hainan Haiyao、Kelun Pharma、Hunan Warrant Pharmaceutical、Borui Bio-Pharmaceutical、Berry Global Group、Inovio Pharmaceuticals
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：5mg、10mg、50mg、100mg
・用途別分析2017年-2028年：病院、クリニック、薬局、その他
・レムデシビル（新型コロナウイルス感染症）の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・レムデシビル（新型コロナウイルス感染症）のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・レムデシビル（新型コロナウイルス感染症）のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・レムデシビル（新型コロナウイルス感染症）の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・レムデシビル（新型コロナウイルス感染症）の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Remdesivir (COVID-19) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Remdesivir (COVID-19) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Remdesivir (COVID-19) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Remdesivir (COVID-19) include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, and Hunan Warrant Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Remdesivir (COVID-19) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5mg
10mg
50mg
100mg
Market segment by Application can be divided into
Hospital
Clinics
Drug Store
Others
The key market players for global Remdesivir (COVID-19) market are listed below:
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Remdesivir (COVID-19) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Remdesivir (COVID-19), with price, sales, revenue and global market share of Remdesivir (COVID-19) from 2019 to 2022.
Chapter 3, the Remdesivir (COVID-19) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remdesivir (COVID-19) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Remdesivir (COVID-19) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Remdesivir (COVID-19).
Chapter 13, 14, and 15, to describe Remdesivir (COVID-19) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Remdesivir (COVID-19) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Remdesivir (COVID-19) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5mg
1.2.3 10mg
1.2.4 50mg
1.2.5 100mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Remdesivir (COVID-19) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Global Remdesivir (COVID-19) Market Size & Forecast
1.4.1 Global Remdesivir (COVID-19) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Remdesivir (COVID-19) Sales in Volume (2017-2028)
1.4.3 Global Remdesivir (COVID-19) Price (2017-2028)
1.5 Global Remdesivir (COVID-19) Production Capacity Analysis
1.5.1 Global Remdesivir (COVID-19) Total Production Capacity (2017-2028)
1.5.2 Global Remdesivir (COVID-19) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Remdesivir (COVID-19) Market Drivers
1.6.2 Remdesivir (COVID-19) Market Restraints
1.6.3 Remdesivir (COVID-19) Trends Analysis
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Remdesivir (COVID-19) Product and Services
2.1.4 Gilead Sciences Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bright Gene
2.2.1 Bright Gene Details
2.2.2 Bright Gene Major Business
2.2.3 Bright Gene Remdesivir (COVID-19) Product and Services
2.2.4 Bright Gene Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hainan Haiyao
2.3.1 Hainan Haiyao Details
2.3.2 Hainan Haiyao Major Business
2.3.3 Hainan Haiyao Remdesivir (COVID-19) Product and Services
2.3.4 Hainan Haiyao Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kelun Pharma
2.4.1 Kelun Pharma Details
2.4.2 Kelun Pharma Major Business
2.4.3 Kelun Pharma Remdesivir (COVID-19) Product and Services
2.4.4 Kelun Pharma Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hunan Warrant Pharmaceutical
2.5.1 Hunan Warrant Pharmaceutical Details
2.5.2 Hunan Warrant Pharmaceutical Major Business
2.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product and Services
2.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Borui Bio-Pharmaceutical
2.6.1 Borui Bio-Pharmaceutical Details
2.6.2 Borui Bio-Pharmaceutical Major Business
2.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product and Services
2.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Berry Global Group
2.7.1 Berry Global Group Details
2.7.2 Berry Global Group Major Business
2.7.3 Berry Global Group Remdesivir (COVID-19) Product and Services
2.7.4 Berry Global Group Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Inovio Pharmaceuticals
2.8.1 Inovio Pharmaceuticals Details
2.8.2 Inovio Pharmaceuticals Major Business
2.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Product and Services
2.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Remdesivir (COVID-19) Breakdown Data by Manufacturer
3.1 Global Remdesivir (COVID-19) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Remdesivir (COVID-19) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Remdesivir (COVID-19)
3.4 Market Concentration Rate
3.4.1 Top 3 Remdesivir (COVID-19) Manufacturer Market Share in 2021
3.4.2 Top 6 Remdesivir (COVID-19) Manufacturer Market Share in 2021
3.5 Global Remdesivir (COVID-19) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Remdesivir (COVID-19) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Remdesivir (COVID-19) Market Size by Region
4.1.1 Global Remdesivir (COVID-19) Sales in Volume by Region (2017-2028)
4.1.2 Global Remdesivir (COVID-19) Revenue by Region (2017-2028)
4.2 North America Remdesivir (COVID-19) Revenue (2017-2028)
4.3 Europe Remdesivir (COVID-19) Revenue (2017-2028)
4.4 Asia-Pacific Remdesivir (COVID-19) Revenue (2017-2028)
4.5 South America Remdesivir (COVID-19) Revenue (2017-2028)
4.6 Middle East and Africa Remdesivir (COVID-19) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Remdesivir (COVID-19) Sales in Volume by Type (2017-2028)
5.2 Global Remdesivir (COVID-19) Revenue by Type (2017-2028)
5.3 Global Remdesivir (COVID-19) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Remdesivir (COVID-19) Sales in Volume by Application (2017-2028)
6.2 Global Remdesivir (COVID-19) Revenue by Application (2017-2028)
6.3 Global Remdesivir (COVID-19) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Remdesivir (COVID-19) Sales by Type (2017-2028)
7.2 North America Remdesivir (COVID-19) Sales by Application (2017-2028)
7.3 North America Remdesivir (COVID-19) Market Size by Country
7.3.1 North America Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
7.3.2 North America Remdesivir (COVID-19) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Remdesivir (COVID-19) Sales by Type (2017-2028)
8.2 Europe Remdesivir (COVID-19) Sales by Application (2017-2028)
8.3 Europe Remdesivir (COVID-19) Market Size by Country
8.3.1 Europe Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
8.3.2 Europe Remdesivir (COVID-19) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Remdesivir (COVID-19) Sales by Type (2017-2028)
9.2 Asia-Pacific Remdesivir (COVID-19) Sales by Application (2017-2028)
9.3 Asia-Pacific Remdesivir (COVID-19) Market Size by Region
9.3.1 Asia-Pacific Remdesivir (COVID-19) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Remdesivir (COVID-19) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Remdesivir (COVID-19) Sales by Type (2017-2028)
10.2 South America Remdesivir (COVID-19) Sales by Application (2017-2028)
10.3 South America Remdesivir (COVID-19) Market Size by Country
10.3.1 South America Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
10.3.2 South America Remdesivir (COVID-19) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Remdesivir (COVID-19) Sales by Type (2017-2028)
11.2 Middle East & Africa Remdesivir (COVID-19) Sales by Application (2017-2028)
11.3 Middle East & Africa Remdesivir (COVID-19) Market Size by Country
11.3.1 Middle East & Africa Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Remdesivir (COVID-19) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Remdesivir (COVID-19)
12.3 Remdesivir (COVID-19) Production Process
12.4 Remdesivir (COVID-19) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Remdesivir (COVID-19) Typical Distributors
13.3 Remdesivir (COVID-19) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Remdesivir (COVID-19) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Remdesivir (COVID-19) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences Major Business
Table 5. Gilead Sciences Remdesivir (COVID-19) Product and Services
Table 6. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bright Gene Basic Information, Manufacturing Base and Competitors
Table 8. Bright Gene Major Business
Table 9. Bright Gene Remdesivir (COVID-19) Product and Services
Table 10. Bright Gene Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Hainan Haiyao Basic Information, Manufacturing Base and Competitors
Table 12. Hainan Haiyao Major Business
Table 13. Hainan Haiyao Remdesivir (COVID-19) Product and Services
Table 14. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kelun Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Kelun Pharma Major Business
Table 17. Kelun Pharma Remdesivir (COVID-19) Product and Services
Table 18. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hunan Warrant Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Hunan Warrant Pharmaceutical Major Business
Table 21. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product and Services
Table 22. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Borui Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Borui Bio-Pharmaceutical Major Business
Table 25. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product and Services
Table 26. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Berry Global Group Basic Information, Manufacturing Base and Competitors
Table 28. Berry Global Group Major Business
Table 29. Berry Global Group Remdesivir (COVID-19) Product and Services
Table 30. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Inovio Pharmaceuticals Major Business
Table 33. Inovio Pharmaceuticals Remdesivir (COVID-19) Product and Services
Table 34. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Remdesivir (COVID-19) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Remdesivir (COVID-19) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Remdesivir (COVID-19), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Remdesivir (COVID-19) Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Remdesivir (COVID-19) Production Site of Key Manufacturer
Table 40. Remdesivir (COVID-19) New Entrant and Capacity Expansion Plans
Table 41. Remdesivir (COVID-19) Mergers & Acquisitions in the Past Five Years
Table 42. Global Remdesivir (COVID-19) Sales by Region (2017-2022) & (K Units)
Table 43. Global Remdesivir (COVID-19) Sales by Region (2023-2028) & (K Units)
Table 44. Global Remdesivir (COVID-19) Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Remdesivir (COVID-19) Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Remdesivir (COVID-19) Sales by Type (2017-2022) & (K Units)
Table 47. Global Remdesivir (COVID-19) Sales by Type (2023-2028) & (K Units)
Table 48. Global Remdesivir (COVID-19) Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Remdesivir (COVID-19) Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Remdesivir (COVID-19) Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Remdesivir (COVID-19) Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Remdesivir (COVID-19) Sales by Application (2017-2022) & (K Units)
Table 53. Global Remdesivir (COVID-19) Sales by Application (2023-2028) & (K Units)
Table 54. Global Remdesivir (COVID-19) Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Remdesivir (COVID-19) Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Remdesivir (COVID-19) Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Remdesivir (COVID-19) Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Remdesivir (COVID-19) Sales by Country (2017-2022) & (K Units)
Table 59. North America Remdesivir (COVID-19) Sales by Country (2023-2028) & (K Units)
Table 60. North America Remdesivir (COVID-19) Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Remdesivir (COVID-19) Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Remdesivir (COVID-19) Sales by Type (2017-2022) & (K Units)
Table 63. North America Remdesivir (COVID-19) Sales by Type (2023-2028) & (K Units)
Table 64. North America Remdesivir (COVID-19) Sales by Application (2017-2022) & (K Units)
Table 65. North America Remdesivir (COVID-19) Sales by Application (2023-2028) & (K Units)
Table 66. Europe Remdesivir (COVID-19) Sales by Country (2017-2022) & (K Units)
Table 67. Europe Remdesivir (COVID-19) Sales by Country (2023-2028) & (K Units)
Table 68. Europe Remdesivir (COVID-19) Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Remdesivir (COVID-19) Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Remdesivir (COVID-19) Sales by Type (2017-2022) & (K Units)
Table 71. Europe Remdesivir (COVID-19) Sales by Type (2023-2028) & (K Units)
Table 72. Europe Remdesivir (COVID-19) Sales by Application (2017-2022) & (K Units)
Table 73. Europe Remdesivir (COVID-19) Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Remdesivir (COVID-19) Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Remdesivir (COVID-19) Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Remdesivir (COVID-19) Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Remdesivir (COVID-19) Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Remdesivir (COVID-19) Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Remdesivir (COVID-19) Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Remdesivir (COVID-19) Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Remdesivir (COVID-19) Sales by Application (2023-2028) & (K Units)
Table 82. South America Remdesivir (COVID-19) Sales by Country (2017-2022) & (K Units)
Table 83. South America Remdesivir (COVID-19) Sales by Country (2023-2028) & (K Units)
Table 84. South America Remdesivir (COVID-19) Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Remdesivir (COVID-19) Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Remdesivir (COVID-19) Sales by Type (2017-2022) & (K Units)
Table 87. South America Remdesivir (COVID-19) Sales by Type (2023-2028) & (K Units)
Table 88. South America Remdesivir (COVID-19) Sales by Application (2017-2022) & (K Units)
Table 89. South America Remdesivir (COVID-19) Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Remdesivir (COVID-19) Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Remdesivir (COVID-19) Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Remdesivir (COVID-19) Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Remdesivir (COVID-19) Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Remdesivir (COVID-19) Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Remdesivir (COVID-19) Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Remdesivir (COVID-19) Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Remdesivir (COVID-19) Sales by Application (2023-2028) & (K Units)
Table 98. Remdesivir (COVID-19) Raw Material
Table 99. Key Manufacturers of Remdesivir (COVID-19) Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Remdesivir (COVID-19) Typical Distributors
Table 103. Remdesivir (COVID-19) Typical Customers
List of Figures
Figure 1. Remdesivir (COVID-19) Picture
Figure 2. Global Remdesivir (COVID-19) Revenue Market Share by Type in 2021
Figure 3. 5mg
Figure 4. 10mg
Figure 5. 50mg
Figure 6. 100mg
Figure 7. Global Remdesivir (COVID-19) Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Drug Store
Figure 11. Others
Figure 12. Global Remdesivir (COVID-19) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Remdesivir (COVID-19) Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Remdesivir (COVID-19) Sales (2017-2028) & (K Units)
Figure 15. Global Remdesivir (COVID-19) Price (2017-2028) & (US$/Unit)
Figure 16. Global Remdesivir (COVID-19) Production Capacity (2017-2028) & (K Units)
Figure 17. Global Remdesivir (COVID-19) Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Remdesivir (COVID-19) Market Drivers
Figure 19. Remdesivir (COVID-19) Market Restraints
Figure 20. Remdesivir (COVID-19) Market Trends
Figure 21. Global Remdesivir (COVID-19) Sales Market Share by Manufacturer in 2021
Figure 22. Global Remdesivir (COVID-19) Revenue Market Share by Manufacturer in 2021
Figure 23. Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Remdesivir (COVID-19) Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Remdesivir (COVID-19) Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Remdesivir (COVID-19) Sales Market Share by Region (2017-2028)
Figure 27. Global Remdesivir (COVID-19) Revenue Market Share by Region (2017-2028)
Figure 28. North America Remdesivir (COVID-19) Revenue (2017-2028) & (USD Million)
Figure 29. Europe Remdesivir (COVID-19) Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Remdesivir (COVID-19) Revenue (2017-2028) & (USD Million)
Figure 31. South America Remdesivir (COVID-19) Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Remdesivir (COVID-19) Revenue (2017-2028) & (USD Million)
Figure 33. Global Remdesivir (COVID-19) Sales Market Share by Type (2017-2028)
Figure 34. Global Remdesivir (COVID-19) Revenue Market Share by Type (2017-2028)
Figure 35. Global Remdesivir (COVID-19) Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Remdesivir (COVID-19) Sales Market Share by Application (2017-2028)
Figure 37. Global Remdesivir (COVID-19) Revenue Market Share by Application (2017-2028)
Figure 38. Global Remdesivir (COVID-19) Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Remdesivir (COVID-19) Sales Market Share by Type (2017-2028)
Figure 40. North America Remdesivir (COVID-19) Sales Market Share by Application (2017-2028)
Figure 41. North America Remdesivir (COVID-19) Sales Market Share by Country (2017-2028)
Figure 42. North America Remdesivir (COVID-19) Revenue Market Share by Country (2017-2028)
Figure 43. United States Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Remdesivir (COVID-19) Sales Market Share by Type (2017-2028)
Figure 47. Europe Remdesivir (COVID-19) Sales Market Share by Application (2017-2028)
Figure 48. Europe Remdesivir (COVID-19) Sales Market Share by Country (2017-2028)
Figure 49. Europe Remdesivir (COVID-19) Revenue Market Share by Country (2017-2028)
Figure 50. Germany Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Remdesivir (COVID-19) Revenue Market Share by Region (2017-2028)
Figure 59. China Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Remdesivir (COVID-19) Sales Market Share by Type (2017-2028)
Figure 66. South America Remdesivir (COVID-19) Sales Market Share by Application (2017-2028)
Figure 67. South America Remdesivir (COVID-19) Sales Market Share by Country (2017-2028)
Figure 68. South America Remdesivir (COVID-19) Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Remdesivir (COVID-19) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Remdesivir (COVID-19) in 2021
Figure 80. Manufacturing Process Analysis of Remdesivir (COVID-19)
Figure 81. Remdesivir (COVID-19) Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のレムデシビル（新型コロナウイルス感染症）市場2022年：5mg、10mg、50mg、100mg(Global Remdesivir (COVID-19) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のレムデシビル（新型コロナウイルス感染症）市場2022年：5mg、10mg、50mg、100mg

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp